Skip to content

SABU PHARMA

Active Private limited companyfounded 2025active for 1 yearLetterkundestraat 64, 2610 AntwerpKBO/BCE: BE 1021.744.847

Lifetime

1 annual account with figures
peak of €37,671 in 2025
€37,671 
peak of €16,544 in 2025
€16,544 
peak of €19,544 in 2025
€19,544 
€500,484 
Board1 name since 2025
1 director
Documentsfilings and deeds
15-06-202646 days before the deadline
2025micro format
Incorporation 03-041 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €150,000 estimated

The micro format states no turnover.

Debts

€500,484 96% of the balance sheet
Financial debts 90%Suppliers 1%Taxes and wages 3%Other 6%

Of this, €46,627 falls due within a year.

Position in the sector

3.8%

Lower solvency than 88% of companies in financial services. The sector median is 51.2%, over 10,288 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 300 sharesdeed of 03-04-2025

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1021744847
Incorporation Founding capital of €3,000, 300 shares · Founded by · appointed as director · published on 03-04-2025 · Gazette deed
First establishment Letterkundestraat 64, Antwerp
All 4 events

Comparable companies

same main activity, similar in size and age
Company
SABU PHARMA Antwerp €520,028 €37,671 3.8% -
NOMAS consultancy Antwerp €564,573 €40,682 41.5% -
JOEL Brasschaat €593,762 €38,791 27.7% -
Gouverneur Business Maasmechelen €525,813 €34,726 4.0% 0
CARO INVEST Ciney €471,947 €41,696 7.8% -
Serendipity Ventures Zemst €606,817 €34,710 0.5% -
PVEX Ans €419,943 €36,704 6.7% -

These companies have the same main activity as SABU PHARMA: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €420,000 and €607,000, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 01-04-2025Normal situation
Activity
Activities of holding companiesNACE 64210and 3 others
Establishment unit
2.371.835.5852610 Antwerp, since 01-04-2025
Financial year end
31 December
Peppol
Reachable since 07-07-2025
Company details

Annual accounts 2025

€520,028
Filing
Filed on 15-06-2026, 46 days before the end of the filing period
Financials

Insights on SABU PHARMA

SABU PHARMA has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19,544 and a net result of €16,544.

Its solvency ranks better than 11% of 10,288 sector peers (NACE 64) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SABU PHARMA

What is the company number of SABU PHARMA?
The company number of SABU PHARMA is 1021.744.847. The VAT number is the same number with BE in front: BE 1021.744.847.
Where is SABU PHARMA based?
The registered office is at Letterkundestraat 64, 2610 Antwerp.Company details
What does SABU PHARMA do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of SABU PHARMA?
SABU PHARMA is a private limited company (BV).
When was SABU PHARMA founded?
SABU PHARMA was founded on 01-04-2025.
Is SABU PHARMA still active?
Yes, SABU PHARMA is an active enterprise in the KBO register.
What is the turnover of SABU PHARMA?
The turnover in financial year 2025 is about €150,000. This figure is estimated from the gross margin of €37,671 and 3,268 comparable companies of the same size. It probably lies between €89,000 and €260,000. It is a rough estimate.Financials
Is SABU PHARMA profitable?
In financial year 2025, SABU PHARMA made a profit of €16,544.
Where can I find the annual accounts of SABU PHARMA?
SABU PHARMA filed 1 annual account with the National Bank of Belgium, for financial year 2025.
When are the next annual accounts of SABU PHARMA due?
SABU PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.